IOVA icon

Iovance Biotherapeutics

250 hedge funds and large institutions have $4.98B invested in Iovance Biotherapeutics in 2021 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 98 increasing their positions, 76 reducing their positions, and 58 closing their positions.

Holders
250
Holders Change
-18
Holders Change %
-6.72%
% of All Funds
4.4%
Holding in Top 10
7
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-36.36%
% of All Funds
0.12%
New
41
Increased
98
Reduced
76
Closed
58
Calls
$37.9M
Puts
$18.9M
Net Calls
+$18.9M
Net Calls Change
-$23.1M
Name Market Value Shares Shares
Change
Shares
Change %
Kayne Anderson Rudnick Investment Management
301
Kayne Anderson Rudnick Investment Management
California
-22 Closed
VCG
302
Vantage Consulting Group
Virginia
-21 Closed
APA
303
American Portfolios Advisors
New York
-20 Closed
IA
304
Inspire Advisors
Idaho
-18 Closed
LC
305
Lindbrook Capital
California
CG
306
Cutler Group
California
MTIM
307
Marathon Trading Investment Management
Pennsylvania
BFM
308
Boothbay Fund Management
New York
CCM
309
CAAS Capital Management
New York
JGC
310
J. Goldman & Co
New York
KCM
311
Kingdon Capital Management
New York
PFBT
312
Parkside Financial Bank & Trust
Missouri
$0 3
SI
313
Sofinnova Investments
California
CAC
314
Cowen and Company
New York
CFGS
315
Concourse Financial Group Securities
Alabama
IC
316
Ikarian Capital
Texas
HT
317
HAP Trading
New York
CM
318
Caption Management
Oklahoma
SM
319
SG3 Management
Puerto Rico
CAM
320
ClariVest Asset Management
California
$0 9
PHS
321
PFM Health Sciences
California
Nomura Asset Management
322
Nomura Asset Management
Japan
TCM
323
Tradewinds Capital Management
Washington
$0 3 +3 New
Simplex Trading
324
Simplex Trading
Illinois
$0 10,327 +10,327 New